U.S. Food and Drug Administration Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products (HCT/Ps)
(Source: What's New at CBER)
Source: What's New at CBER - June 10, 2015 Category: Biomedical Science Source Type: news

FDA Update: Relevant to Reproductive Establishments
(Source: What's New at CBER)
Source: What's New at CBER - June 10, 2015 Category: Biomedical Science Source Type: news

FDA Update
(Source: What's New at CBER)
Source: What's New at CBER - June 10, 2015 Category: Biomedical Science Source Type: news

October 11, 2007 Transcripts
(Source: What's New at CBER)
Source: What's New at CBER - June 10, 2015 Category: Biomedical Science Source Type: news

October 12, 2007 Transcripts
(Source: What's New at CBER)
Source: What's New at CBER - June 10, 2015 Category: Biomedical Science Source Type: news

July 22, 2004 Approval Letter
(Source: What's New at CBER)
Source: What's New at CBER - June 10, 2015 Category: Biomedical Science Source Type: news

CBER’s Sentinel Program
(Source: What's New at CBER)
Source: What's New at CBER - April 17, 2015 Category: Biomedical Science Source Type: news

Determining the Need for and Content of Environmental Assessments for Gene Therapies, Vectored Vaccines, and Related Recombinant Viral or Microbial Products; Guidance for Industry
(Source: What's New at CBER)
Source: What's New at CBER - March 23, 2015 Category: Biomedical Science Source Type: news

CBER FY 2013 Recall Postings
(Source: What's New at CBER)
Source: What's New at CBER - March 12, 2015 Category: Biomedical Science Source Type: news

Package Insert and Patient Information - Rotarix
CBER Rotarix Product Approval Information (Source: What's New at CBER)
Source: What's New at CBER - March 2, 2015 Category: Biomedical Science Source Type: news

Biologics Guidances
(Source: What's New at CBER)
Source: What's New at CBER - February 24, 2015 Category: Biomedical Science Source Type: news

Generics
(Source: What's New at CBER)
Source: What's New at CBER - February 24, 2015 Category: Biomedical Science Source Type: news

Investigating and Reporting Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Regulated Solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271; Draft Guidance
(Source: What's New at CBER)
Source: What's New at CBER - February 19, 2015 Category: Biomedical Science Source Type: news

Investigating and Reporting Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Regulated Solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271 - Draft
(Source: What's New at CBER)
Source: What's New at CBER - February 18, 2015 Category: Biomedical Science Source Type: news

Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2015
(Source: What's New at CBER)
Source: What's New at CBER - January 23, 2015 Category: Biomedical Science Source Type: news